About Forest Neurotech

Our mission is to advance healthcare by making neurotechnology accessible, less invasive, and adaptable across a range of neurological conditions. 

Our work holds promise for millions worldwide suffering from conditions like Parkinson’s disease, treatment-resistant depression, and cognitive-motor dissociation in critical care settings.

Forest’s Nonprofit Advantage


In March 2024, Convergent Research announced support from former Google CEO Eric Schmidt and Wendy Schmidt to Forest Neurotech*. As a Focused Research Organization (FRO), Forest Neurotech is a new breed of nonprofit startup. FROs are an innovative funding structure engineered to support moonshot efforts that create new scientific tools and datasets. As a FRO, Forest can focus on impactful applications and scientific dissemination, ensuring maximum public benefit without commercial constraints. Forest's state-of-the-art tools, research, and discoveries will be shared with the broader scientific community, aligning with its commitment to open science.



*In addition to support from Eric Schmidt, Forest Neurotech has received funding from Griffin Catalyst, the philanthropic organization of Citadel CEO Kenneth C. Griffin, the Riley & Susan Bechtel Foundation, and James Fickel.




Forest’s Team


Forest Neurotech was founded in October 2023 by two Caltech scientists and a founding team member of Verily, building on recent breakthroughs in ultrasound neurotechnologies. Our multidisciplinary team of experts — from physics, engineering, and translational neuroscience — brings experience from Stanford, Meta, Google, Caltech, and UC Berkeley.

Forest is guided by a distinguished group of advisors from Caltech, Google, Columbia University, Neuropace, and OpenAI.








Founders

Sumner L. Norman, Ph.D.
Co-founder, CEO

Formerly
Chief Neuroscientist, AE Studio
Postdoctoral Scholar, Caltech
Tyson Aflalo, Ph.D.
Co-founder, CSO

FormerlyScientific Director, Chen BMI Center, Caltech
William Biederman, Ph.D. Co-founder, CTO

Formerly
Head of Dexcom G7 CGM Program, Verily
Founding team, Verily



Advisors
Mikhail Shapiro, Ph.D.
Professor of Chemistry & Chemical Engineering, Caltech
HHMI Investigator

Formerly
Third Rock Ventures, Cyberkinetics
Elisa Konofagou, Ph.D.
Professor of Biomedical Engineering & Radiology, Columbia University

Pioneer in ultrasound neuromodulation
Wojciech Zaremba, Ph.D. 
Co-Founder of OpenAI

Pioneer in ML/AI
Frank Fischer
Founder of Neuropace

40 yr. senior management in medical device field
Brian Otis, Ph.D.
Co-founder and former CTO of Verily Life Sciences

Industry veteran  and visionary in the life sciences technology field
Noah Richmond, J.D, Ph.D
Principal, Ecosystem Frameworks Strategy at Google





  Home     About     Technology 
Get Involved:    Spec Sheet     Patient Eligibility     Jobs

© Forest Neurotech, LLC  2024, Terms & Conditions + Privacy Policy  
     🧠